Greenwich LifeSciences, Inc.
GLSI
$16.80
$0.422.56%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 462.90K | 518.20K | 355.20K | 653.10K | 352.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.02M | 5.73M | 7.95M | 4.17M | 3.77M |
| Operating Income | -4.02M | -5.73M | -7.95M | -4.17M | -3.77M |
| Income Before Tax | -3.95M | -5.66M | -7.92M | -4.15M | -3.75M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.95M | -5.66M | -7.92M | -4.15M | -3.75M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.95M | -5.66M | -7.92M | -4.15M | -3.75M |
| EBIT | -4.02M | -5.73M | -7.95M | -4.17M | -3.77M |
| EBITDA | -4.02M | -5.73M | -7.95M | -4.17M | -3.77M |
| EPS Basic | -0.27 | -0.39 | -0.57 | -0.30 | -0.28 |
| Normalized Basic EPS | -0.17 | -0.24 | -0.35 | -0.19 | -0.18 |
| EPS Diluted | -0.27 | -0.39 | -0.57 | -0.30 | -0.28 |
| Normalized Diluted EPS | -0.17 | -0.24 | -0.35 | -0.19 | -0.18 |
| Average Basic Shares Outstanding | 14.62M | 14.57M | 13.95M | 13.64M | 13.37M |
| Average Diluted Shares Outstanding | 14.62M | 14.57M | 13.95M | 13.64M | 13.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |